1. Home
  2. |Insights
  3. |Health Tech Investor Event: Bridging European Innovation and U.S. Markets

Health Tech Investor Event: Bridging European Innovation and U.S. Markets

Event | 10.18.24

Address

Crowell NY Office
375 9th Avenue
New York, NY

Join us for an exclusive event in New York City, where European startups meet investors eager to bring groundbreaking healthtech solutions to the American market.
This invite-only event, in collaboration with MEDVIA, Flanders Investment & Trade, Smart Hub Flemish Brabant, Crowell, and StrtupBoost, offers a unique opportunity to witness the future of health technology. Six pioneering Belgian companies will pitch their innovative solutions across medtech, biotech, and digital health. This is your chance to engage with leading health tech startups and connect with investors driving change in the healthcare sector.
For Investors: Are you looking to expand your portfolio with cutting-edge health tech solutions? This event offers a curated selection of startups primed for U.S. market entry, each with strong traction in Europe. Secure your spot to network with like-minded investors and discover new opportunities in health technology.
For Startups: Is your startup ready to break into the U.S. health tech market? Join us for a chance to pitch in front of leading investors and gain valuable insights into what it takes to succeed in the U.S. healthcare space.
Interested in attending?
Attendance is free and based on an application process. Please RSVP, and we will review your application to confirm your spot.

For more information, please visit these areas: Corporate — Brussels Practice, Emerging Companies and Venture Capital

Insights

Event | 02.20.25

Has the Buss Stopped? Recoupment Today

Has the Buss Stopped? Recoupment Today: In 1997, the California Supreme Court decided Buss v. Superior Court. In Buss, the court concluded that a liability insurer that defended a mixed action could seek reimbursement from the insured for the defense costs associated with the claims that were not even potentially covered. Since then, numerous courts have held that insurers are entitled to recoup their defense costs associated with uncovered claims or causes of action. On the other hand, a significant number of courts have rejected insurers’ right to recoupment, at least in the absence of a policy provision granting the insurer that right. Some commentators have even suggested that the current judicial trend might be away from permitting insurers to recoup their defense costs. Is that correct? Has the Buss stopped? This panel of coverage experts will analyze insurers’ claimed right to recoupment today, and offer their perspectives on what the law on recoupment should perhaps be and might be in the future.